Log in
NYSE:CTK

CooTek (Cayman) Stock Forecast, Price & News

$5.10
+0.10 (+2.00 %)
(As of 09/22/2020 12:00 AM ET)
Add
Compare
Today's Range
$4.95
Now: $5.10
$5.10
50-Day Range
$4.90
MA: $5.65
$6.95
52-Week Range
$4.55
Now: $5.10
$7.45
Volume4,720 shs
Average Volume44,435 shs
Market Capitalization$324.39 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.01
CooTek (Cayman) Inc. operates as an AI and big data-driven mobile Internet company. Its primary product is TouchPal Smart Input, an input method for mobile devices that supports approximately 110 languages worldwide. The company was founded in 2008 and is based in Shanghai, the People's Republic of China.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.2Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.41 out of 5 stars


Industry, Sector and Symbol

Industry Data processing & preparation
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone86-21-6485-6352

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$177.88 million
Book Value$0.61 per share

Profitability

Net Income$-36,850,000.00

Miscellaneous

EmployeesN/A
Market Cap$324.39 million
Next Earnings Date11/16/2020 (Estimated)
OptionableNot Optionable
$5.10
+0.10 (+2.00 %)
(As of 09/22/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CTK News and Ratings via Email

Sign-up to receive the latest news and ratings for CTK and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











CooTek (Cayman) (NYSE:CTK) Frequently Asked Questions

How has CooTek (Cayman)'s stock price been impacted by Coronavirus (COVID-19)?

CooTek (Cayman)'s stock was trading at $6.54 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CTK stock has decreased by 22.0% and is now trading at $5.10.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of CooTek (Cayman)?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CooTek (Cayman) in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for CooTek (Cayman)
.

When is CooTek (Cayman)'s next earnings date?

CooTek (Cayman) is scheduled to release its next quarterly earnings announcement on Monday, November 16th 2020.
View our earnings forecast for CooTek (Cayman)
.

How were CooTek (Cayman)'s earnings last quarter?

CooTek (Cayman) Inc. (NYSE:CTK) released its quarterly earnings results on Monday, August, 17th. The company reported $0.05 EPS for the quarter, beating the Zacks' consensus estimate of $0.01 by $0.04. The firm had revenue of $126.40 million for the quarter, compared to the consensus estimate of $120.50 million. CooTek (Cayman) had a negative net margin of 8.84% and a negative return on equity of 83.47%.
View CooTek (Cayman)'s earnings history
.

What guidance has CooTek (Cayman) issued on next quarter's earnings?

CooTek (Cayman) issued an update on its third quarter 2020 Pre-Market earnings guidance on Tuesday, August, 18th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $112-112 million, compared to the consensus revenue estimate of $138.63 million.

What price target have analysts set for CTK?

3 analysts have issued 1 year target prices for CooTek (Cayman)'s stock. Their forecasts range from $7.00 to $14.00. On average, they anticipate CooTek (Cayman)'s share price to reach $9.50 in the next year. This suggests a possible upside of 86.3% from the stock's current price.
View analysts' price targets for CooTek (Cayman)
.

Who are some of CooTek (Cayman)'s key competitors?

What other stocks do shareholders of CooTek (Cayman) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CooTek (Cayman) investors own include Opko Health (OPK), QUALCOMM (QCOM), AbbVie (ABBV), AngloGold Ashanti (AU), Baidu (BIDU), Carnival (CCL), Inovio Pharmaceuticals (INO), Newmont Goldcorp (NEM), NVIDIA (NVDA) and Teladoc Health (TDOC).

Who are CooTek (Cayman)'s key executives?

CooTek (Cayman)'s management team includes the following people:
  • Mr. Kan Zhang, Chairman of Directors & Chief Architect (Age 39)
  • Mr. Jialiang Wang, CEO & Director (Age 40)
  • Ms. Qiaoling Li, Pres & Director (Age 41)
  • Ms. Liqin Zhang, Chief Financial Officer (Age 40)
  • Mr. Jian Wang, CTO & Director (Age 39)

When did CooTek (Cayman) IPO?

(CTK) raised $57 million in an initial public offering on Friday, September 28th 2018. The company issued 4,400,000 shares at a price of $12.00-$14.00 per share. Credit Suisse, BofA Merrill Lynch and Citigroup served as the underwriters for the IPO.

What is CooTek (Cayman)'s stock symbol?

CooTek (Cayman) trades on the New York Stock Exchange (NYSE) under the ticker symbol "CTK."

How do I buy shares of CooTek (Cayman)?

Shares of CTK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is CooTek (Cayman)'s stock price today?

One share of CTK stock can currently be purchased for approximately $5.10.

How big of a company is CooTek (Cayman)?

CooTek (Cayman) has a market capitalization of $324.39 million and generates $177.88 million in revenue each year. The company earns $-36,850,000.00 in net income (profit) each year or ($0.58) on an earnings per share basis.

What is CooTek (Cayman)'s official website?

The official website for CooTek (Cayman) is www.cootek.com.

How can I contact CooTek (Cayman)?

CooTek (Cayman)'s mailing address is 9-11F NO.16 LANE 399 XINLONG ROAD MINHANG DISTRICT, SHANGHAI F4, 201101. The company can be reached via phone at 86-21-6485-6352 or via email at [email protected]

This page was last updated on 9/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.